Since the introduction of the first closed-loop system in the 1960s and 1970s, advancements in diabetes management have been closely tied to innovations in diabetes technology, particularly the widespread adoption of continuous insulin delivery systems and glucose monitoring devices [16,17]. This evidence concerns the gene INS and diabetes mellitus.